Erik Ostrowski
CIK 1762507 · SVP, CFO, CBO & Treasurer · last filed 2026-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AKBA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
245 FIRST STREET
CAMBRIDGE, MA 02142
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKBA | SVP, CFO, CBO & Treasurer | 616,616 | $0.42 | $261.9K | -$262.4K | 6 | 2026-07-01 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | Interim CEO, President and CFO | 2,440 | $16.80 | $41.0K | $0 | 9 | 2024-02-05 |
10b5-1 Trading Plans
2 plans · 2 in force| Company | Adopted | Sales Can Start | Ends | Plan Allows | Sold So Far | Status | Link |
|---|---|---|---|---|---|---|---|
| AKBA Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer |
Sep 8, 2025 | Dec 7, 2025 | — | — | 90,970 last filed Jul 1, 2026 |
Active | 10-Q |
| AKBA Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer |
Jun 21, 2024 | Sep 19, 2024 | — | — | 97,333 last filed Jul 1, 2026 |
Active | 10-Q |
Recent Filings · Page 2 of 2
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-07-03 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-10 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-09 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-04 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-04 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-06 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-04 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | +2,300 | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).